Pharmacological Chaperones for the Treatment of α-Mannosidosis.

Abstract

α-Mannosidosis (AM) results from deficient lysosomal α-mannosidase (LAMAN) activity and subsequent substrate accumulation in the lysosome, leading to severe pathology. Many of the AM-causative mutations compromise enzyme folding and could be rescued with purpose-designed pharmacological chaperones (PCs). We found that PCs combining a LAMAN glycone-binding motif based on the 5 N,6 O-oxomethylidenemannojirimycin (OMJ) glycomimetic core and different aglycones, in either mono- or multivalent displays, elicit binding modes involving glycone and nonglycone enzyme regions that reinforce the protein folding and stabilization potential. Multivalent derivatives exhibited potent enzyme inhibition that generally prevailed over the chaperone effect. On the contrary, monovalent OMJ derivatives with LAMAN aglycone binding area-fitting substituents proved effective as activity enhancers for several mutant LAMAN forms in AM patient fibroblasts and/or transfected MAN2 B1-KO cells. This translated into a significant improvement in endosomal/lysosomal function, reverting not only the primary LAMAN substrate accumulation but also the additional downstream consequences such as cholesterol accumulation.

• Authors: Rocío Rísquez-Cuadro, Reimi Matsumoto, Fernando Ortega-Caballero, Eiji Nanba, Katsumi Higaki, José Manuel García Fernández, Carmen Ortiz Mellet
• Journal: Journal of medicinal chemistry (J Med Chem) Vol. 62 Issue 12 Pg. 5832-5843 (06 27 2019) ISSN: 1520-4804 [Electronic] United States
• PMID: 31017416 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Glycosides
• Imino Pyranoses
• alpha-Mannosidase

Topics

• Amino Acid Motifs
• Cell Line
• Drug Design
• Fibroblasts (drug effects, metabolism)
• Glycosides (chemistry)
• Humans
• Imino Pyranoses (chemistry, pharmacology, therapeutic use)
• alpha-Mannosidase (chemistry, metabolism)
• alpha-Mannosidosis (drug therapy, metabolism)